Mrna Vaccine Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0087924
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:6.77
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 6.77 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
SummarymRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global mRNA Vaccine market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2026, growing at a CAGR of xx% between 2019 and 2026.
This report studies the mRNA Vaccine market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2026; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of mRNA Vaccine in these regions, from 2014 to 2026, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
By the product type, the market is primarily split into
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By the end users/application, this report covers the following segments
Infectious Disease
Cancer
Other
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global mRNA Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2026.
To understand the structure of mRNA Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global mRNA Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the mRNA Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of mRNA Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of mRNA Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
This report includes the estimation of market size for value (million USD) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of mRNA Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of mRNA Vaccine market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table of Contents
1 mRNA Vaccine Market Overview
1.1 mRNA Vaccine Product Overview
1.2 mRNA Vaccine Market Segment by Type
1.2.1 Standardization Of Cancer Treatment MRNA Vaccine
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Global mRNA Vaccine Market Size by Type
1.3.1 Global mRNA Vaccine Sales and Growth by Type
1.3.2 Global mRNA Vaccine Sales and Market Share by Type (2014-2019)
1.3.3 Global mRNA Vaccine Revenue and Market Share by Type (2014-2019)
1.3.4 Global mRNA Vaccine Price by Type (2014-2019)
2 Global mRNA Vaccine Market Competition by Company
2.1 Global mRNA Vaccine Sales and Market Share by Company (2014-2019)
2.2 Global mRNA Vaccine Revenue and Share by Company (2014-2019)
2.3 Global mRNA Vaccine Price by Company (2014-2019)
2.4 Global Top Players mRNA Vaccine Manufacturing Base Distribution, Sales Area, Product Types
2.5 mRNA Vaccine Market Competitive Situation and Trends
2.5.1 mRNA Vaccine Market Concentration Rate
2.5.2 Global mRNA Vaccine Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 mRNA Vaccine Company Profiles and Sales Data
3.1 Moderna Therapeutics
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 mRNA Vaccine Product Category, Application and Specification
3.1.3 Moderna Therapeutics mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 CureVac
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 mRNA Vaccine Product Category, Application and Specification
3.2.3 CureVac mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Translate Bio
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 mRNA Vaccine Product Category, Application and Specification
3.3.3 Translate Bio mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 BioNTech
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 mRNA Vaccine Product Category, Application and Specification
3.4.3 BioNTech mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Sangamo Therapeutics
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 mRNA Vaccine Product Category, Application and Specification
3.5.3 Sangamo Therapeutics mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Argos Therapeutics
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 mRNA Vaccine Product Category, Application and Specification
3.6.3 Argos Therapeutics mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 In-Cell-Art
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 mRNA Vaccine Product Category, Application and Specification
3.7.3 In-Cell-Art mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 eTheRNA
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 mRNA Vaccine Product Category, Application and Specification
3.8.3 eTheRNA mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Ethris
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 mRNA Vaccine Product Category, Application and Specification
3.9.3 Ethris mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Tiba Biotechnology
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 mRNA Vaccine Product Category, Application and Specification
3.10.3 Tiba Biotechnology mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
4 mRNA Vaccine Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global mRNA Vaccine Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global mRNA Vaccine Sales and Revenue by Regions
4.2.1 Global mRNA Vaccine Sales and Market Share by Regions (2014-2019)
4.2.2 Global mRNA Vaccine Revenue and Market Share by Regions (2014-2019)
4.2.3 Global mRNA Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America mRNA Vaccine Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe mRNA Vaccine Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific mRNA Vaccine Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America mRNA Vaccine Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa mRNA Vaccine Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 mRNA Vaccine Application/End Users
5.1 mRNA Vaccine Segment by Application
5.1.1 Infectious Disease
5.1.2 Cancer
5.1.3 Other
5.2 Global mRNA Vaccine Product Segment by Application
5.2.1 Global mRNA Vaccine Sales by Application
5.2.2 Global mRNA Vaccine Sales and Market Share by Application (2014-2019)
6 Global mRNA Vaccine Market Forecast
6.1 Global mRNA Vaccine Sales, Revenue Forecast (2019-2025)
6.1.1 Global mRNA Vaccine Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global mRNA Vaccine Revenue and Growth Rate Forecast (2019-2025)
6.2 Global mRNA Vaccine Forecast by Regions
6.2.1 North America mRNA Vaccine Sales and Revenue Forecast (2019-2025)
6.2.2 Europe mRNA Vaccine Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific mRNA Vaccine Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America mRNA Vaccine Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa mRNA Vaccine Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 mRNA Vaccine Forecast by Type
6.3.1 Global mRNA Vaccine Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Standardization Of Cancer Treatment MRNA Vaccine Gowth Forecast
6.3.3 Individualized Cancer Treatment MRNA Vaccine Gowth Forecast
6.4 mRNA Vaccine Forecast by Application
6.4.1 Global mRNA Vaccine Sales Forecast by Application (2019-2025)
6.4.2 Global mRNA Vaccine Forecast in Infectious Disease
6.4.3 Global mRNA Vaccine Forecast in Cancer
7 mRNA Vaccine Upstream Raw Materials
7.1 mRNA Vaccine Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 mRNA Vaccine Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure mRNA Vaccine Product Picture
Figure Global mRNA Vaccine Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global mRNA Vaccine Sales (K Doses) Status and Outlook (2014-2025)
Figure Product Picture of Standardization Of Cancer Treatment MRNA Vaccine
Table Major Players of Standardization Of Cancer Treatment MRNA Vaccine
Figure Global Standardization Of Cancer Treatment MRNA Vaccine Sales (K Doses) and Growth Rate (%)(2014-2018)
Figure Product Picture of Individualized Cancer Treatment MRNA Vaccine
Table Major Players of Individualized Cancer Treatment MRNA Vaccine
Figure Global Individualized Cancer Treatment MRNA Vaccine Sales (K Doses) and Growth Rate (%)(2014-2019)
Figure Product Picture of Infectious Disease Treatment MRNA Vaccine
Table Major Players of Infectious Disease Treatment MRNA Vaccine
Figure Global Infectious Disease Treatment MRNA Vaccine Sales (K Doses) and Growth Rate (%)(2014-2019)
Figure Product Picture of Infection Prevention MRNA Vaccine
Table Major Players of Infection Prevention MRNA Vaccine
Figure Global Infection Prevention MRNA Vaccine Sales (K Doses) and Growth Rate (%)(2014-2019)
Table Global mRNA Vaccine Sales (K Doses) and Growth Rate (%) Comparison by Type
Table Global mRNA Vaccine Sales (K Doses) by Type (2014-2019)
Table Global mRNA Vaccine Sales Share (%) by Type (2014-2019)
Figure Global mRNA Vaccine Sales Market Share (%) by Type (2014-2019)
Figure Global mRNA Vaccine Sales Market Share (%) by Type in 2018
Table Global mRNA Vaccine Revenue (Million USD) by Type (2014-2019)
Table Global mRNA Vaccine Revenue Share (%) by Type (2014-2019)
Figure Global mRNA Vaccine Revenue Share (%) by Type (2014-2019)
Figure 2018 Global mRNA Vaccine Revenue Market Share (%) by Type
Table Global mRNA Vaccine Price (USD/Dose) by Type (2014-2019)
Table Global mRNA Vaccine Sales (K Doses) by Company (2014-2019)
Table Global mRNA Vaccine Sales Share (%) by Company (2014-2019)
Figure Global mRNA Vaccine Sales Share (%) by Company in 2018
Table Global mRNA Vaccine Revenue (Million USD) by Company (2014-2019)
Table Global mRNA Vaccine Revenue Share (%) by Company (2014-2019)
Figure Global mRNA Vaccine Revenue Share (%) by Company in 2018
Table Global Market mRNA Vaccine Average Price (USD/Dose) by Company (2014-2019)
Table Global mRNA Vaccine Top Players Manufacturing Base Distribution and Sales Area
Table Global mRNA Vaccine Top Players Product Category
Figure Global mRNA Vaccine Market Share (%) of Top 5 Players
Figure Global mRNA Vaccine Market Share (%) of Top 10 Players
Table Moderna Therapeutics Basic Information List
Table Moderna Therapeutics mRNA Vaccine Product Category, Application and Specification
Table Moderna Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Moderna Therapeutics mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Moderna Therapeutics mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table CureVac Basic Information List
Figure CureVac mRNA Vaccine Product Category, Application and Specification
Table CureVac mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure CureVac mRNA Vaccine Sales Growth Rate (2014-2019)
Figure CureVac mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Translate Bio Basic Information List
Figure Translate Bio mRNA Vaccine Product Category, Application and Specification
Table Translate Bio mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Translate Bio mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Translate Bio mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table BioNTech Basic Information List
Figure BioNTech mRNA Vaccine Product Category, Application and Specification
Table BioNTech mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure BioNTech mRNA Vaccine Sales Growth Rate (2014-2019)
Figure BioNTech mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Sangamo Therapeutics Basic Information List
Figure Sangamo Therapeutics mRNA Vaccine Product Category, Application and Specification
Table Sangamo Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Sangamo Therapeutics mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Sangamo Therapeutics mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Argos Therapeutics Basic Information List
Figure Argos Therapeutics mRNA Vaccine Product Category, Application and Specification
Table Argos Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Argos Therapeutics mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Argos Therapeutics mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table In-Cell-Art Basic Information List
Figure In-Cell-Art mRNA Vaccine Product Category, Application and Specification
Table In-Cell-Art mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure In-Cell-Art mRNA Vaccine Sales Growth Rate (2014-2019)
Figure In-Cell-Art mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table eTheRNA Basic Information List
Figure eTheRNA mRNA Vaccine Product Category, Application and Specification
Table eTheRNA mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure eTheRNA mRNA Vaccine Sales Growth Rate (2014-2019)
Figure eTheRNA mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Ethris Basic Information List
Figure Ethris mRNA Vaccine Product Category, Application and Specification
Table Ethris mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Ethris mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Ethris mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Tiba Biotechnology Basic Information List
Figure Tiba Biotechnology mRNA Vaccine Product Category, Application and Specification
Table Tiba Biotechnology mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Tiba Biotechnology mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Tiba Biotechnology mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Global mRNA Vaccine Market Size Comparison by Regions (2014-2025)
Figure North America mRNA Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific mRNA Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe mRNA Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America mRNA Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa mRNA Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global mRNA Vaccine Sales (K Doses) by Regions (2014-2019)
Table Global mRNA Vaccine Sales Market Share (%) by Regions (2014-2019)
Figure Global mRNA Vaccine Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global mRNA Vaccine Sales Market Share (%) by Regions
Table Global mRNA Vaccine Revenue (Million USD) by Regions (2014-2019)
Table Global mRNA Vaccine Revenue Market Share (%) by Regions (2014-2019)
Figure Global mRNA Vaccine Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global mRNA Vaccine Revenue Market Share (%) by Regions
Table Global mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure North America mRNA Vaccine Sales Growth Rate
Table North America mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure United States mRNA Vaccine Sales (K Doses)(2014-2019)
Figure United States mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Canada mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Canada mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Mexico mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Mexico mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Europe mRNA Vaccine Sales Growth Rate
Table Europe mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Germany mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Germany mRNA Vaccine Revenue (Million USD) (2014-2019)
Figure UK mRNA Vaccine Sales (K Doses)(2014-2019)
Figure UK mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure France mRNA Vaccine Sales (K Doses)(2014-2019)
Figure France mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Italy mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Italy mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Russia mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Russia mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Turkey mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Turkey mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Asia-Pacific mRNA Vaccine Sales Growth Rate
Table Asia-Pacific mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure China mRNA Vaccine Sales (K Doses)(2014-2019)
Figure China mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Japan mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Japan mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Korea mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Korea mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Southeast Asia mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Southeast Asia mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Indonesia mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Indonesia mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Thailand mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Thailand mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Malaysia mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Malaysia mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Philippines mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Philippines mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Vietnam mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Vietnam mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure India mRNA Vaccine Sales (K Doses)(2014-2019)
Figure India mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Australia mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Australia mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure South America mRNA Vaccine Sales Growth Rate
Table South America mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Brazil mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Brazil mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Middle East and Africa mRNA Vaccine Sales Growth Rate
Table Middle East and Africa mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure North Africa mRNA Vaccine Sales (K Doses)(2014-2019)
Figure North Africa mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure GCC Countries mRNA Vaccine Sales (K Doses)(2014-2019)
Figure GCC Countries mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Infectious Disease Examples
Figure Cancer Examples
Figure Other Examples
Table Global mRNA Vaccine Sales (K Doses) Comparison by Application (2014-2025)
Table Global mRNA Vaccine Sales (K Doses) by Application (2014-2019)
Table Global mRNA Vaccine Sales Share (%) by Application (2014-2019)
Figure Global mRNA Vaccine Sales Market Share (%) by Application (2014-2019)
Figure Global mRNA Vaccine Sales Market Share (%) by Application in 2018
Figure Global mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Global mRNA Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global mRNA Vaccine Sales (K Doses) Forecast by Regions (2019-2025)
Figure Global mRNA Vaccine Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure North America mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Europe mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure China mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Japan mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Korea mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure India mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Australia mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure South America mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global mRNA Vaccine Sales (Million USD) Forecast by Type (2019-2025)
Figure Global mRNA Vaccine Sales Market Share (%) Forecast by Type (2019-2025)
Table Global mRNA Vaccine Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global mRNA Vaccine Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Standardization Of Cancer Treatment MRNA Vaccine Sales Growth Forecast
Figure Individualized Cancer Treatment MRNA Vaccine Sales Growth Forecast
Table Global mRNA Vaccine Sales (K Doses) Forecast by Application (2019-2025)
Figure Global mRNA Vaccine Sales Forecast by Application (2019-2025)
Figure Global mRNA Vaccine Sales (K Doses) Forecast in Infectious Disease
Figure Global mRNA Vaccine Sales (K Doses) Forecast in Cancer
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure mRNA Vaccine Manufacturing Cost Structure
Figure mRNA Vaccine Industrial Chain Analysis
Table Distributors List
Table mRNA Vaccine Downstream Customers
1 mRNA Vaccine Market Overview
1.1 mRNA Vaccine Product Overview
1.2 mRNA Vaccine Market Segment by Type
1.2.1 Standardization Of Cancer Treatment MRNA Vaccine
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Global mRNA Vaccine Market Size by Type
1.3.1 Global mRNA Vaccine Sales and Growth by Type
1.3.2 Global mRNA Vaccine Sales and Market Share by Type (2014-2019)
1.3.3 Global mRNA Vaccine Revenue and Market Share by Type (2014-2019)
1.3.4 Global mRNA Vaccine Price by Type (2014-2019)
2 Global mRNA Vaccine Market Competition by Company
2.1 Global mRNA Vaccine Sales and Market Share by Company (2014-2019)
2.2 Global mRNA Vaccine Revenue and Share by Company (2014-2019)
2.3 Global mRNA Vaccine Price by Company (2014-2019)
2.4 Global Top Players mRNA Vaccine Manufacturing Base Distribution, Sales Area, Product Types
2.5 mRNA Vaccine Market Competitive Situation and Trends
2.5.1 mRNA Vaccine Market Concentration Rate
2.5.2 Global mRNA Vaccine Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 mRNA Vaccine Company Profiles and Sales Data
3.1 Moderna Therapeutics
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 mRNA Vaccine Product Category, Application and Specification
3.1.3 Moderna Therapeutics mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 CureVac
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 mRNA Vaccine Product Category, Application and Specification
3.2.3 CureVac mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Translate Bio
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 mRNA Vaccine Product Category, Application and Specification
3.3.3 Translate Bio mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 BioNTech
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 mRNA Vaccine Product Category, Application and Specification
3.4.3 BioNTech mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Sangamo Therapeutics
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 mRNA Vaccine Product Category, Application and Specification
3.5.3 Sangamo Therapeutics mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Argos Therapeutics
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 mRNA Vaccine Product Category, Application and Specification
3.6.3 Argos Therapeutics mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 In-Cell-Art
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 mRNA Vaccine Product Category, Application and Specification
3.7.3 In-Cell-Art mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 eTheRNA
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 mRNA Vaccine Product Category, Application and Specification
3.8.3 eTheRNA mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Ethris
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 mRNA Vaccine Product Category, Application and Specification
3.9.3 Ethris mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Tiba Biotechnology
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 mRNA Vaccine Product Category, Application and Specification
3.10.3 Tiba Biotechnology mRNA Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
4 mRNA Vaccine Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global mRNA Vaccine Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global mRNA Vaccine Sales and Revenue by Regions
4.2.1 Global mRNA Vaccine Sales and Market Share by Regions (2014-2019)
4.2.2 Global mRNA Vaccine Revenue and Market Share by Regions (2014-2019)
4.2.3 Global mRNA Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America mRNA Vaccine Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe mRNA Vaccine Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific mRNA Vaccine Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America mRNA Vaccine Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa mRNA Vaccine Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 mRNA Vaccine Application/End Users
5.1 mRNA Vaccine Segment by Application
5.1.1 Infectious Disease
5.1.2 Cancer
5.1.3 Other
5.2 Global mRNA Vaccine Product Segment by Application
5.2.1 Global mRNA Vaccine Sales by Application
5.2.2 Global mRNA Vaccine Sales and Market Share by Application (2014-2019)
6 Global mRNA Vaccine Market Forecast
6.1 Global mRNA Vaccine Sales, Revenue Forecast (2019-2025)
6.1.1 Global mRNA Vaccine Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global mRNA Vaccine Revenue and Growth Rate Forecast (2019-2025)
6.2 Global mRNA Vaccine Forecast by Regions
6.2.1 North America mRNA Vaccine Sales and Revenue Forecast (2019-2025)
6.2.2 Europe mRNA Vaccine Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific mRNA Vaccine Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America mRNA Vaccine Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa mRNA Vaccine Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 mRNA Vaccine Forecast by Type
6.3.1 Global mRNA Vaccine Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Standardization Of Cancer Treatment MRNA Vaccine Gowth Forecast
6.3.3 Individualized Cancer Treatment MRNA Vaccine Gowth Forecast
6.4 mRNA Vaccine Forecast by Application
6.4.1 Global mRNA Vaccine Sales Forecast by Application (2019-2025)
6.4.2 Global mRNA Vaccine Forecast in Infectious Disease
6.4.3 Global mRNA Vaccine Forecast in Cancer
7 mRNA Vaccine Upstream Raw Materials
7.1 mRNA Vaccine Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 mRNA Vaccine Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure mRNA Vaccine Product Picture
Figure Global mRNA Vaccine Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global mRNA Vaccine Sales (K Doses) Status and Outlook (2014-2025)
Figure Product Picture of Standardization Of Cancer Treatment MRNA Vaccine
Table Major Players of Standardization Of Cancer Treatment MRNA Vaccine
Figure Global Standardization Of Cancer Treatment MRNA Vaccine Sales (K Doses) and Growth Rate (%)(2014-2018)
Figure Product Picture of Individualized Cancer Treatment MRNA Vaccine
Table Major Players of Individualized Cancer Treatment MRNA Vaccine
Figure Global Individualized Cancer Treatment MRNA Vaccine Sales (K Doses) and Growth Rate (%)(2014-2019)
Figure Product Picture of Infectious Disease Treatment MRNA Vaccine
Table Major Players of Infectious Disease Treatment MRNA Vaccine
Figure Global Infectious Disease Treatment MRNA Vaccine Sales (K Doses) and Growth Rate (%)(2014-2019)
Figure Product Picture of Infection Prevention MRNA Vaccine
Table Major Players of Infection Prevention MRNA Vaccine
Figure Global Infection Prevention MRNA Vaccine Sales (K Doses) and Growth Rate (%)(2014-2019)
Table Global mRNA Vaccine Sales (K Doses) and Growth Rate (%) Comparison by Type
Table Global mRNA Vaccine Sales (K Doses) by Type (2014-2019)
Table Global mRNA Vaccine Sales Share (%) by Type (2014-2019)
Figure Global mRNA Vaccine Sales Market Share (%) by Type (2014-2019)
Figure Global mRNA Vaccine Sales Market Share (%) by Type in 2018
Table Global mRNA Vaccine Revenue (Million USD) by Type (2014-2019)
Table Global mRNA Vaccine Revenue Share (%) by Type (2014-2019)
Figure Global mRNA Vaccine Revenue Share (%) by Type (2014-2019)
Figure 2018 Global mRNA Vaccine Revenue Market Share (%) by Type
Table Global mRNA Vaccine Price (USD/Dose) by Type (2014-2019)
Table Global mRNA Vaccine Sales (K Doses) by Company (2014-2019)
Table Global mRNA Vaccine Sales Share (%) by Company (2014-2019)
Figure Global mRNA Vaccine Sales Share (%) by Company in 2018
Table Global mRNA Vaccine Revenue (Million USD) by Company (2014-2019)
Table Global mRNA Vaccine Revenue Share (%) by Company (2014-2019)
Figure Global mRNA Vaccine Revenue Share (%) by Company in 2018
Table Global Market mRNA Vaccine Average Price (USD/Dose) by Company (2014-2019)
Table Global mRNA Vaccine Top Players Manufacturing Base Distribution and Sales Area
Table Global mRNA Vaccine Top Players Product Category
Figure Global mRNA Vaccine Market Share (%) of Top 5 Players
Figure Global mRNA Vaccine Market Share (%) of Top 10 Players
Table Moderna Therapeutics Basic Information List
Table Moderna Therapeutics mRNA Vaccine Product Category, Application and Specification
Table Moderna Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Moderna Therapeutics mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Moderna Therapeutics mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table CureVac Basic Information List
Figure CureVac mRNA Vaccine Product Category, Application and Specification
Table CureVac mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure CureVac mRNA Vaccine Sales Growth Rate (2014-2019)
Figure CureVac mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Translate Bio Basic Information List
Figure Translate Bio mRNA Vaccine Product Category, Application and Specification
Table Translate Bio mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Translate Bio mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Translate Bio mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table BioNTech Basic Information List
Figure BioNTech mRNA Vaccine Product Category, Application and Specification
Table BioNTech mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure BioNTech mRNA Vaccine Sales Growth Rate (2014-2019)
Figure BioNTech mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Sangamo Therapeutics Basic Information List
Figure Sangamo Therapeutics mRNA Vaccine Product Category, Application and Specification
Table Sangamo Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Sangamo Therapeutics mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Sangamo Therapeutics mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Argos Therapeutics Basic Information List
Figure Argos Therapeutics mRNA Vaccine Product Category, Application and Specification
Table Argos Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Argos Therapeutics mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Argos Therapeutics mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table In-Cell-Art Basic Information List
Figure In-Cell-Art mRNA Vaccine Product Category, Application and Specification
Table In-Cell-Art mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure In-Cell-Art mRNA Vaccine Sales Growth Rate (2014-2019)
Figure In-Cell-Art mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table eTheRNA Basic Information List
Figure eTheRNA mRNA Vaccine Product Category, Application and Specification
Table eTheRNA mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure eTheRNA mRNA Vaccine Sales Growth Rate (2014-2019)
Figure eTheRNA mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Ethris Basic Information List
Figure Ethris mRNA Vaccine Product Category, Application and Specification
Table Ethris mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Ethris mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Ethris mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Tiba Biotechnology Basic Information List
Figure Tiba Biotechnology mRNA Vaccine Product Category, Application and Specification
Table Tiba Biotechnology mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Tiba Biotechnology mRNA Vaccine Sales Growth Rate (2014-2019)
Figure Tiba Biotechnology mRNA Vaccine Sales Global Market Share (%)(2014-2019)
Table Global mRNA Vaccine Market Size Comparison by Regions (2014-2025)
Figure North America mRNA Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific mRNA Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe mRNA Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America mRNA Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa mRNA Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global mRNA Vaccine Sales (K Doses) by Regions (2014-2019)
Table Global mRNA Vaccine Sales Market Share (%) by Regions (2014-2019)
Figure Global mRNA Vaccine Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global mRNA Vaccine Sales Market Share (%) by Regions
Table Global mRNA Vaccine Revenue (Million USD) by Regions (2014-2019)
Table Global mRNA Vaccine Revenue Market Share (%) by Regions (2014-2019)
Figure Global mRNA Vaccine Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global mRNA Vaccine Revenue Market Share (%) by Regions
Table Global mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure North America mRNA Vaccine Sales Growth Rate
Table North America mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure United States mRNA Vaccine Sales (K Doses)(2014-2019)
Figure United States mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Canada mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Canada mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Mexico mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Mexico mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Europe mRNA Vaccine Sales Growth Rate
Table Europe mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Germany mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Germany mRNA Vaccine Revenue (Million USD) (2014-2019)
Figure UK mRNA Vaccine Sales (K Doses)(2014-2019)
Figure UK mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure France mRNA Vaccine Sales (K Doses)(2014-2019)
Figure France mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Italy mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Italy mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Russia mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Russia mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Turkey mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Turkey mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Asia-Pacific mRNA Vaccine Sales Growth Rate
Table Asia-Pacific mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure China mRNA Vaccine Sales (K Doses)(2014-2019)
Figure China mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Japan mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Japan mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Korea mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Korea mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Southeast Asia mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Southeast Asia mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Indonesia mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Indonesia mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Thailand mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Thailand mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Malaysia mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Malaysia mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Philippines mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Philippines mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Vietnam mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Vietnam mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure India mRNA Vaccine Sales (K Doses)(2014-2019)
Figure India mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Australia mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Australia mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure South America mRNA Vaccine Sales Growth Rate
Table South America mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Brazil mRNA Vaccine Sales (K Doses)(2014-2019)
Figure Brazil mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Middle East and Africa mRNA Vaccine Sales Growth Rate
Table Middle East and Africa mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure North Africa mRNA Vaccine Sales (K Doses)(2014-2019)
Figure North Africa mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure GCC Countries mRNA Vaccine Sales (K Doses)(2014-2019)
Figure GCC Countries mRNA Vaccine Revenue (Million USD)(2014-2019)
Figure Infectious Disease Examples
Figure Cancer Examples
Figure Other Examples
Table Global mRNA Vaccine Sales (K Doses) Comparison by Application (2014-2025)
Table Global mRNA Vaccine Sales (K Doses) by Application (2014-2019)
Table Global mRNA Vaccine Sales Share (%) by Application (2014-2019)
Figure Global mRNA Vaccine Sales Market Share (%) by Application (2014-2019)
Figure Global mRNA Vaccine Sales Market Share (%) by Application in 2018
Figure Global mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Global mRNA Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global mRNA Vaccine Sales (K Doses) Forecast by Regions (2019-2025)
Figure Global mRNA Vaccine Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure North America mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Europe mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure China mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Japan mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Korea mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure India mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Australia mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure South America mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries mRNA Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries mRNA Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global mRNA Vaccine Sales (Million USD) Forecast by Type (2019-2025)
Figure Global mRNA Vaccine Sales Market Share (%) Forecast by Type (2019-2025)
Table Global mRNA Vaccine Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global mRNA Vaccine Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Standardization Of Cancer Treatment MRNA Vaccine Sales Growth Forecast
Figure Individualized Cancer Treatment MRNA Vaccine Sales Growth Forecast
Table Global mRNA Vaccine Sales (K Doses) Forecast by Application (2019-2025)
Figure Global mRNA Vaccine Sales Forecast by Application (2019-2025)
Figure Global mRNA Vaccine Sales (K Doses) Forecast in Infectious Disease
Figure Global mRNA Vaccine Sales (K Doses) Forecast in Cancer
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure mRNA Vaccine Manufacturing Cost Structure
Figure mRNA Vaccine Industrial Chain Analysis
Table Distributors List
Table mRNA Vaccine Downstream Customers
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"